• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.58% Nasdaq Up 0.26%

    More On KYTH

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Kythera Biopharmaceuticals, Inc. (KYTH)

    -NasdaqGS
    74.98 0.00(0.00%) Sep 30, 4:00PM EDT
    Prev Close:74.98
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:68.33
    Beta:-0.376137
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:29.86 - 76.31
    Volume:0
    Avg Vol (3m):636,730
    Market Cap:1.97B
    P/E (ttm):N/A
    EPS (ttm):-4.77
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for KYTH

    Comparison

    Symbol% ChgMkt Cap
    KYTH 0.00%1.97B
    ZLTQUp 2.11%1.51B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :N/A
    Quarterly EPS Est (Sep-15) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    KYTHERA Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of prescription products for the aesthetic medicine market in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback